MAP (MAP) News
Follow MAP (MAP) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Genetic Signatures Says Microba Shareholders to Hold 60% of GSS After Merger
MNA | Oct 21, 2026, 01:37 AM UTC
L
Microba Life Sciences Appoints Geoffrey Cockerill As Interim CEO
Microba Life Sciences Ltd ASX:MAP
NEWS | Sep 25, 2026, 01:11 AM UTC
M
Genetic Signatures and Microba agree principal terms for all-scrip merger
Genetic Signatures (ASX:GSS) and Microba Life Sciences (ASX:MAP) have agreed on principal commercial terms for an all-scrip merger to form a larger Australian diagnostics group with complementary technologies, products,
MNA | Sep 22, 2026, 01:21 AM UTC
M
Mapfre solvency ratio rises to 208.8% at end of H1
Mapfre SA reports a solvency ratio of 208.8% at end of H1.
EQUITY | Sep 04, 2026, 07:36 AM UTC